Difference between revisions of "Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) (Q10987)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: named entity (P78): Coronaviridae (species) (Q10871), #quickstatements; #temporary_batch_1592937423256)
(‎Created claim: named entity (P78): angiotensin I converting enzyme 2 (gene) (Q10876), #quickstatements; #temporary_batch_1592937423256)
Property / named entity
 +
Property / named entity: angiotensin I converting enzyme 2 (gene) / rank
 +
Normal rank

Revision as of 18:37, 23 June 2020

Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
Language Label Description Also known as
English
Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2)
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2

    Statements

    0 references